Close
Help
Login
Staff Login
Register
0
Selected
Invert selection
Deselect all
Deselect all
Add to Cart
Click here to refresh results
Click here to refresh results
Go to Login page
Hide details
Conceptually similar
CP123262421 | N.S. pauses use of AstraZeneca vaccine
CP120960271 | Nova Scotia to expand use of Oxford-AstraZeneca vaccine to those 55-64
CP122404571 | Quebec reports first blood clot death in woman who received AstraZeneca vaccine
CP122830710 | New Brunswick reports blood clot death in connection with Oxford-AstraZeneca vaccine
CP121635062 | AstraZeneca vaccine to remain authorized in Canada
CP120474321 | Nova Scotia's vaccine plan aims to vaccinate residents by end of June
CP120852971 | Oxford-AstraZeneca suspension doesn't mean vaccine is unsafe: N.S. top doctor
CP118971421 | AstraZeneca vaccine authorized in Canada
CP123774871 | Ontario to resume AstraZeneca shots for COVID-19 as second dose
CP121911021 | B.C. expands restrictions, AstraZeneca vaccine
Placeline/People
City
Vaughan
Country
Canada
N.S. to start administering AstraZeneca vaccines
Nova Scotia residents aged 63 and 64 will be the first to receive the newly approved AstraZeneca vaccine starting next week. Officials say 13,000 doses of the vaccine will be administered on a first come, first served basis in 25 different locations across the province starting March 20.
Actions
Add to collection
Add to cart
Information
Source name:
The Canadian Press
Unique identifier:
CP119781421
Legacy Identifier:
n_COVID-NS20210309T1352
Type:
Video
Duration:
2m22s
Dimensions:
1920px × 1080px 160.42 MB
Usage rights:
FOR ONE TIME USE ONLY. NO STORAGE FOR FUTURE USE.
Create Date:
3/9/2021 1:52:00 PM
Display aspect ratio:
16:9
Tags
age group
AstraZeneca
COVID-19
Nova Scotia
vaccinations
vaccine